Non-small cell lung cancers carrying mutant TP53 but not mutant NRF2 or KEAPl displayed higher levels of NRF2 mRNA than wild-type TP53 tumors [163]. This evidence concerns the gene NFE2L2 and non-small cell lung carcinoma.